Related Experiment Video
Updated: Aug 16, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
Recurrent Histoplasma capsulatum pneumonia: a case report
M Tinelli1, G Michelone, C Cavanna
1Institute of Infectious Diseases, IRCSS-Policlinico S. Matteo, Pavia, Italy.
Abstract:
The epidemiological, clinical and therapeutical findings are described in a case of recurrent pulmonary histoplasmosis due to Histoplasma capsulatum. The patient, a bulldozer-operator, worked in Africa for a long period in extremely dusty conditions without any protection. Three different episodes of H. capsulatum pneumonia recurred during eighteen months after his return from Africa. A full dose treatment by Amphotericin B failed to eliminate disease recurrence on three occasions. The high concentration of airborne H. capsulatum spores inhaled could have been the main cause of the difficulty obtaining a rapid sterilization of the microorganism by Amphotericin B and disease recurrence. The late start of the treatment or the unexplained ability of some persons to develop repeated infections even with normal immunological parameters could be another explanation for the reported phenomenon.
Insights
Recurrent pulmonary histoplasmosis in a patient exposed to Histoplasma capsulatum spores in Africa proved difficult to treat. Amphotericin B failed to prevent repeated infections, suggesting high spore concentration or host factors may play a role.
Area of Science:
- Mycology
- Infectious Diseases
- Pulmonology
Background:
- Pulmonary histoplasmosis is a fungal infection caused by Histoplasma capsulatum.
- Occupational exposure to fungal spores can lead to respiratory infections.
Observation:
- A case study of a bulldozer operator with recurrent pulmonary histoplasmosis after working in dusty conditions in Africa.
- The patient experienced three episodes of H. capsulatum pneumonia within 18 months post-return.
Findings:
- Standard Amphotericin B treatment failed to resolve the recurrent infections.
- High airborne spore concentration is hypothesized as a factor hindering sterilization and promoting recurrence.
- Delayed treatment initiation or individual host immune factors may also contribute to persistent infections.
Implications:
- This case highlights challenges in treating severe or recurrent pulmonary histoplasmosis.
- Understanding factors contributing to treatment failure is crucial for managing endemic fungal infections.
- Further research into host-pathogen interactions in recurrent fungal pneumonia is warranted.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Atypical Pneumonia
Cryptococcal Meningitis
Pneumonia I: Introduction

